Group One Trading’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-124,900
| Closed | -$4.18M | – | 8419 |
|
|
2026
Q1 | $4.18M | Buy |
124,900
+97,400
| +354% | +$3.82M | 0.01% | 1440 |
|
|
2025
Q4 | $1.27M | Buy |
27,500
+4,100
| +18% | +$225K | ﹤0.01% | 2683 |
|
|
2025
Q3 | $1.58M | Sell |
23,400
-3,300
| -12% | -$245K | ﹤0.01% | 2551 |
|
|
2025
Q2 | $2.24M | Sell |
26,700
-185,500
| -87% | -$13.9M | ﹤0.01% | 2033 |
|
|
2025
Q1 | $15.2M | Buy |
212,200
+91,400
| +76% | +$4.45M | 0.04% | 422 |
|
|
2024
Q4 | $5.43M | Buy |
120,800
+117,800
| +3,927% | +$6.1M | 0.01% | 1101 |
|
|
2024
Q3 | $151K | Buy |
+3,000
| New | +$144K | ﹤0.01% | 3862 |
|
|
2023
Q1 | – | Sell |
-10,900
| Closed | -$21.6K | – | 7904 |
|
|
2022
Q4 | $21.6K | Hold |
10,900
| – | – | ﹤0.01% | 5558 |
|
|
2022
Q3 | $18K | Buy |
10,900
+10,173
| +1,399% | +$24.8K | ﹤0.01% | 6148 |
|
|
2022
Q2 | $2K | Sell |
727
-73
| -9% | -$202 | ﹤0.01% | 7441 |
|
|
2022
Q1 | $3K | Sell |
800
-2,353
| -75% | -$12.2K | ﹤0.01% | 7652 |
|
|
2021
Q4 | $19K | Sell |
3,153
-454
| -13% | -$4.76K | ﹤0.01% | 7010 |
|
|
2021
Q3 | $50K | Sell |
3,607
-440
| -11% | -$6.14K | ﹤0.01% | 6550 |
|
|
2021
Q2 | $69K | Sell |
4,047
-1,440
| -26% | -$24.3K | ﹤0.01% | 6308 |
|
|
2021
Q1 | $104K | Buy |
5,487
+5,440
| +11,574% | +$175K | ﹤0.01% | 5632 |
|
|
2020
Q4 | $1K | Sell |
47
-2,260
| -98% | -$65.2K | ﹤0.01% | 6352 |
|
|
2020
Q3 | $87K | Buy |
2,307
+1,987
| +621% | +$58.1K | ﹤0.01% | 4289 |
|
|
2020
Q2 | $11K | Buy |
+320
| New | +$13.9K | ﹤0.01% | 5087 |
|
Group One Trading's SLNO Position: Q2 2026 in Review
Group One Trading sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 19,953 shares — an estimated $668K sold.
Group One Trading first reported a position in SLNO in Q3 2020 and held it in 19 quarters. The position peaked at $1.04M in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.
- Group One Trading reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
- Group One Trading sold 19,953 Soleno Therapeutics shares in Q2 2026, an estimated $668K.
- Group One Trading first reported a position in Soleno Therapeutics in Q3 2020 and held it in 19 quarters.
- Group One Trading's Soleno Therapeutics position peaked at $1.04M in Q4 2025.
- 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.